Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 41, 2011 - Issue 3
136
Views
4
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Pharmacokinetics of the prodrug thiamphenicol glycinate and its active parent compound thiamphenicol in beagle dogs following intravenous administration

, , , , , , & show all
Pages 226-231 | Received 03 Aug 2010, Accepted 24 Oct 2010, Published online: 23 Nov 2010

References

  • Abdennebi EH, Sawchuk RJ, Stowe CM. (1994a). Thiamphenicol pharmacokinetics in beef and dairy cattle. J Vet Pharmacol Ther 17:365–368.
  • Abdennebi EH, Khales N, Sawchuk RJ, Stowe CM. (1994b). Thiamphenicol pharmacokinetics in sheep. J Vet Pharmacol Ther 17:12–16.
  • Al-Nazawi MH. (2005). Pharmacokinetics and tolerance of thiamphenicol in camels and sheep. Int J Pharmacol 1:25–28.
  • Drago L, De Vecchi E, Fassina MC, Mombelli B, Gismondo MR. (2000). Serum and lung levels of thiamphenicol after administration of its glycinate N-acetylcysteinate ester in experimentally infected guinea pigs. Int J Antimicrob Agents 13:301–303.
  • Francis PG. (1997). Residues of some veterinary drugs in animals and foods. FAO Food Nutr Pap 41:89–104.
  • Intorre L, Castells G, Cristòfol C, Bertini S, Soldani G, Arboix M. (2002). Residue depletion of thiamphenicol in the sea-bass. J Vet Pharmacol Ther 25:59–63.
  • Kitamura T, Ando J, Ishihara R, Takano S, Iijima T, Nishimura S, Yoshida M, Takahashi M, Maekawa A. (1997). Lack of carcinogenicity of thiamphenicol in F344 rats. Food Chem Toxicol 35:1075–1080.
  • Li S, Maxwell RJ, Shadwell RJ. (2002). Solubility of amphenicol bacteriostats in CO2. Fluid Phase Equilibria 198:67–80.
  • Papich MG, Riviere JE. (2001). Chloramphenicol and derivatives, macrolides, lincosamides and miscellaneous antimicrobials. In: Adams HR, ed. Veterinary Pharmacology and Therapeutics. Iowa State University Press: Ames IA, pp. 868–897.
  • Phensri T, Chotima P. (2005). High-performance liquid chromatographic determination of enalapril in human plasma by enzyme kinetic analytical method. J Pharmaceut Biomed 37:763–769.
  • Tullio V, Cuffini A, Mandras N, Roana J, Banche G, Ungheri D, Carlone N. (2004). Influence of thiamphenicol on the primary functions of human polymorphonuclear leucocytes against Streptococcus pyogenes. Int J Antimicrob Agents 24:381–385.
  • Turton JA, Andrews CM, Havard AC, Robinson S, York M, Williams TC, Gibson FM. (2002). Haemotoxicity of thiamphenicol in the BALB/c mouse and Wistar Hanover rat. Food Chem Toxicol 40:1849–1861.
  • Turton JA, Havard AC, Robinson S, Holt DE, Andrews CM, Fagg R, Williams TC. (2000). An assessment of chloramphenicol and thiamphenicol in the induction of aplastic anaemia in the BALB/c mouse. Food Chem Toxicol 38:925–938.
  • US FDA. (2001). Guidance for Industry: Bioanalytical Method Validation. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf
  • Weller S, Blum MR, Doucette M, Burnette T, Cederberg DM, de Miranda P, Smiley ML. (1993). Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers. Clin Pharmacol Ther 54:595–605.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.